ERICKA TAYLOR-DANIEL: Open Payments
NPI 1992186142 · ROANOKE RAPIDS, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,932 in 71 payments from 19 companies in 2025. Trend: 2023 $22,498 · 2024 $7,643 · 2025 $6,932
Speaker / faculty: $4,500Food & beverage: $1,572Travel & lodging: $748Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $5,547 |
| Otsuka America Pharmaceutical, Inc. | 5 | $190 |
| Teva Pharmaceuticals USA, Inc. | 8 | $183 |
| Neurocrine BioSciences, Inc. | 9 | $178 |
| Janssen Pharmaceuticals, Inc | 3 | $136 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $111 |
| Lundbeck LLC | 4 | $97 |
| Alkermes, Inc. | 4 | $89 |
| E.R. Squibb & Sons, L.L.C. | 3 | $67 |
| Vanda Pharmaceuticals Inc. | 2 | $57 |
Products named: MAVYRET, INGREZZA, ABILIFY MAINTENA, INVEGA SUSTENNA, CAPLYTA, REXULTI, AUSTEDO XR, COBENFY.
Industry payments across NC — which companies pay providers there.
